Prevalence of disabilities in patients with multiple sclerosis at the neuroimmunology outpatient clinic
DOI:
https://doi.org/10.22491/2357-9730.145376Keywords:
Multiple Sclerosis, Muscle Weakness, Fatigue, Mobility LimitationAbstract
Introduction: Multiple Sclerosis (MS) presents a variety of signs and symptoms, such as muscle weakness, fatigue, spasticity, interfering with quality of life. These symptoms cause some disabilities as the disease progresses. Objective: To identify the prevalence of disabilities in patients with multiple sclerosis of the relapsing-remitting type at the Neuroimmunology Outpatient Clinic of the Hospital de Clínicas de Porto Alegre (HCPA), between the years 2016 and 2022. Methodology: Retrospective longitudinal epidemiological study, with a follow-up period it was 2 (Group A), 3 (Group B) and 4 to 6 (Group C) years, according to the period between the evaluation and reevaluation of physiotherapy. Data on fatigue, muscle strength, tone, functional mobility, independence and quality of life were analyzed. Descriptive statistics were performed with analysis of frequencies and central tendency and dispersion. Results: 35 patients were studied (A, n= 14; B, n=11; C, n= 10). The median EDSS (Expanded Disability Status Scale) at reassessment in the three groups was 2.5. The time to diagnosis ranged from 7.9±5.5 to 13.9±7.9 at reevaluation. There was a change in muscle tone and strength in all patients. Most patients reported a feeling of fatigue in both assessments. Functional mobility remained preserved in most cases, while there was an improvement in quality of life over time in all groups. Conclusion: This study made it possible to identify the presence of disabilities in patients with multiple sclerosis, showing that the most common changes were muscle weakness, feelings of fatigue and spasticity.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Mauren Andrielli dos Anjos Carvalho, Claudia Tarragô Candotti, Luciano Rodrigues Palmeiro

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).